A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Scientists have identified a simple blood test that measures insulin resistance which may also help doctors determine which ...

A blood test for insulin resistance (a hallmark of diabetes) may offer clues about the speed of memory loss for people with early Alzheimer’s disease.

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

Four out of 10 U.S. adults ages 18 to 44 have insulin resistance—and most don’t even know it. But what is insulin resistance, ...

The craziest way science has found to help reverse insulin resistance is drinking lemon juice. Scientific research is now ...

Type 2 diabetes (T2D) results from the cells’ insulin resistance, and to date, insulin therapy and diabetes medications targeting glycemic management have failed to reverse the increase in T2D ...

A post hoc analysis of the SRMOUNT-1 study finds weight loss from the use of tirzepatide was associated with strong benefits ...